"Pancreatic Cancer Advances" ed. by Luis Rodrigo

This book aims to provide an update in the current state of play in pancreatic cancer diagnosis and to evaluate the benefits and limitations of the available diagnostic technology and therapy.

Pancreatic cancer is a growing source of cancer-related death and has poor survival rates, which have not improved in the last few decades. Its high-mortality rate is attributed to pancreatic cancer biology, difficulty in early diagnosis, and lack of standardized international guidelines in assessing the pancreatic masses. The main modalities for diagnosis are imaging with HCT, MRI, USE, and PET. Some chapters review the improvements in the techniques used. Timely and accurate diagnosis of pancreatic cancer can lead to improve in the current poor outcome of this disease.

Contents
1. Systemic Inflammatory Response in Pancreatic Ductal Adenocarcinoma
2. Pancreatic Cancer, Leptin, and Chemoresistance: Current Challenges
3. Sporadic Pancreatic Cancer: Glucose Homeostasis and Pancreatogenic Type 3 Diabetes
4. Endoscopic Ultrasound in Pancreatic Cancer
5. Irreversible Electroporation in Pancreatic Cancer
6. Enhanced Electric Pulse Technology for the Ablation of Pancreatic Cancer
7. Pancreatic Resections for Metastatic Disease
8. Drug Discovery from Natural Products for Pancreatic Cancer
9. Neoadjuvant Treatment for Nonmetastatic Pancreatic Cancer
10. The Role of Neoadjuvant Therapy in Surgical Treatment of Pancreatic Cancer